ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Mechanistic insights into the renoprotective effects of rutin-loaded selenium nanoparticles against 5-fluorouracil toxicity via regulation of Nrf2/Keap1, NF-κB/NLRP3, and PERK pathways.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
5-Fluorouracil (5-FU) is a mainstay chemotherapeutic compound in the management of solid neoplasia; however, its clinical application is frequently restricted by significant nephrotoxicity. This study was performed to assess the renal protective impact of rutin (RUT), sodium selenite (Na₂SeO₃), and green-synthesized selenium nanoparticles (SeNPs) functionalized with rutin (RUT-SeNPs) in an animal model of 5-FU-provoked renal injury. Thirty-five rats were divided arbitrarily into 5 equal groups: normal control, 5-FU, 5-FU&Na₂SeO₃, 5-FU&RUT, and 5-FU&RUT-SeNPs. Application of 5-FU caused pronounced renal dysfunction, characterized by marked elevations in conventional and early kidney injury biomarkers, profound oxidative stress, activation of inflammatory signaling routes including NF-κB, and stimulation of apoptotic cascades, together with depletion of endogenous antioxidant defenses. Although treatment with RUT or Na₂SeO₃ afforded partial renal protection, RUT-SeNPs demonstrated superior efficacy by markedly attenuating functional, oxidative, inflammatory, and apoptotic derangements and restoring antioxidant homeostasis toward physiological levels. These biological and molecular findings were substantiated by histopathological and immunohistochemical analyses, which revealed preservation of renal architecture and a significant reduction in inflammatory and apoptotic lesions. Collectively, these results highlight RUT-SeNPs as a promising nanotherapeutic approach for alleviating 5-FU-induced nephrotoxicity.
Indexed as
Identifiers
42909586What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.